Remove 2021 Remove Drug Pricing Remove Prescription Filling
article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

Overall, while the NHC appreciates CMS’ intent to streamline the data submission process and make it more accessible, we encourage ongoing dialogue and adjustments to ensure that the process remains patient-centered, efficient, and capable of capturing the full spectrum of information necessary to inform meaningful drug price negotiations.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). This includes collecting data on utilization management practices, formulary changes, and patient experiences.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Lilly Digest

Ramblings of a pharmacist

The 1957 Lilly Digest reveals that that’s below average - the typical survey-respondent pharmacy did 13502 prescriptions/year. Grandpa’s 31,766th prescription. Anyway – on to the current issue of the Digest (which is the 2021 Digest that summarizes data from 2020 operations). prescription transaction.

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

12 Mark Kyle and Natalie Keating, “Prior Authorization and Association with Delayed or Discontinued Prescription Fills,” Journal of Clinical Oncology 42, no. September 2021. link] Health-Care-Costs-2021-Recommendations.pdf. link] Health-Care-Costs-2021-Recommendations.pdf. 18 National Health Council.

article thumbnail

January 2025 Newsletter

Safe Biologics

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?